The global MLCC (Multi‑Layer Ceramic Capacitor) market has seen a new round of price increases in Q3 2026. Samsung Electro‑Mechanics implemented price hikes of up to 30% effective August 1, while Taiyo Yuden is set to follow with price adjustments in September. Driven by surging demand for AI computing power, shortages of high‑capacity MLCCs have spilled over into PCBA manufacturing for medical and industrial hardware.
Component manufacturers are prioritizing capacity allocation for AI server applications, tightening supply for high‑reliability, high‑capacity MLCCs required by medical devices. Key capacitor models for many medical projects now face lead‑times extending beyond 20 weeks. Standard PCBA order lead‑times in South China have stretched to 12‑14 weeks. Even when PCBs and housings are ready, shortages of a single critical MLCC can halt full‑batch production and delay the launch of overseas medical ODM projects.
Strict reliability and compliance requirements prevent medical hardware from freely swapping component parts, further amplifying supply‑chain risks. Many overseas buyers and hardware engineers report discovering MLCC price surges or part obsolescence only during BOM review, facing dual pressure on cost and delivery schedules.
Industry practitioners recommend conducting early component risk checks at the BOM review stage, evaluating alternative parts and local replacement options, and securing inventory for critical components in advance. For medical‑grade PCBA orders, supply‑chain partners should carry out proactive BOM risk assessment. Price volatility and component lead‑times shall be factored into quotations to help overseas clients mitigate project‑delay risks.
